RESULTS
Between January 1, 2010 and December 31, 2020, 175 patients underwent
SVT ablation. 15% of these patients were being treated with psychiatric
medications and were included in the final study population. Patient
characteristics can be found in Table 1. The average age was 50.08 +
17.92 years. 57.7% were female. 26.9% had been diagnosed with
hypertension. 65.4% of PSVT patients taking psychiatric medications had
a formal diagnosis of generalized anxiety disorder. In terms of medical
management, 46.2% of these patients were on beta blockers, 3.9% on
calcium channel blockers, 15.4% on antiarrhythmic medications, and
3.9% on direct oral anticoagulants (DOACs). With regards to
presentation of PSVT, the most common symptoms reported were
palpitations (80.77%), followed by dizziness (42.31%), and shortness
of breath (34.62%) (Figure 1).